Eyestem: Funding, Investors & Team (Sep 2026)
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.
Eyestem has raised $16.4M across 2 funding rounds on record, the most recent a Series B of $10.0M announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eyestem Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Eyestem Funding Rounds
Eyestem raised $6.4M in a Series A announced in Aug 2022.
3 years later, a Series B of $10.0M was announced in Aug 2025.
Eyestem Founders and Leadership Team
No contact details are on record for this team yet.
Eyestem Funding Compared to Other Biotechnology Startups
Eyestem's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eyestem in Biotechnology and Bengaluru
Companies Similar to Eyestem
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
BrainSightAI is a software platform that uses MRI technology to improve accuracy in neurological and…
Agbiotech startup that envisions a world where good yields are an assurance and not a gamble despite the…
Eyestem Funding FAQs
What does Eyestem do?
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.
How much funding has Eyestem raised?
Eyestem has raised $16.4M across 2 rounds on record. The most recent is a Series B of $10.0M announced in Aug 2025.
When did Eyestem last raise funding?
Eyestem's most recent funding round on record is a Series B of $10.0M, announced in Aug 2025.
Who founded Eyestem?
FundedIQ lists Rajani Battu (Founder) at Eyestem.
Where is Eyestem headquartered?
Eyestem is based in Bengaluru, Karnataka, India.
How many employees does Eyestem have?
Eyestem is in the 11-50 employee band.
How does Eyestem's funding compare to other Biotechnology startups?
Eyestem's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Eyestem Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eyestem is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.